QR-koda

Home-Based FeNO Monitoring with the Vivatmo me Device Reveals Type 2 Inflammatory Patterns of Patients with Asthma at Different Treatment Steps: The FeNO@Home Study

Abstract Introduction Fractional exhaled nitric oxide (FeNO) is an important type 2 (T2) asthma biomarker. Home-based FeNO monitoring can provide longitudinal data better reflecting the variable nature of T2 inflammation versus single-point data. We sought to compare longitudinal mean FeNO and varia...

Olles dieđut

Furkejuvvon:
Váldodahkkit: Kai M. Beeh, Tim Harrison, Enrico Heffler, Hartmut Timmermann, Stephan Weber, Sandra Wegner
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: Adis, Springer Healthcare 2025-12-01
Ráidu:Pulmonary Therapy
Fáttát:
Asthma
Exhaled nitric oxide
Diagnosis
Inflammation monitoring
Biomarker
Asthma control
Liŋkkat:https://doi.org/10.1007/s41030-025-00336-9
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid